Double chin is a common aesthetic problem for both men and women. Whether she has grown older or is the result of a change in weight, the double chin has so far been ineffectually treated. BELKYRA is the first in class effective therapy for men and women who want to remove their double chin and improve their profile.
BELKYRA is the only approved therapy from the American Academy of Food and Drug Administration (FDA), which irreversibly breaks down the fat cells under the chin. The active ingredient of BELKYRA is deoxycholic acid, a molecule that helps to break down and absorb fat in the body.
BELKYRA is a safe injection therapy that takes place within 15-20 minutes. The dermatologist determines the therapeutic course according to the individual needs of the patient. The visible improvements are observed after 2 to 4 procedures. Some patients may be given up to 6 therapies to achieve the best effect. Once the desired results are achieved, re-treatment is not necessary.
Is there a recovery period after the treatment?
In most people, restoration time is minimal. Some malaise may occur after the first therapy, but no breakdown or postponement of work is required. After the procedure, it is possible to get a slight swelling, which means the product is working. It is possible that redness, hematoma, tingling or itching may occur.
Therapy is only suitable for the elderly. It is not recommended for the treatment of pregnant or lactating women. Therapy is also not recommended for people who are hypersensitive to deoxycholic acid, patients with thyroid disease, impaired circulation, renal or hepatic impairment.
Which are the right patients for BELKYRA?
Potential candidates for therapy with BELKYRA are those who eat healthily and exercise, but nevertheless, the double chin does not disappear.